COVID Vaccine Developer/Manufacturer Announcements

Milestones :: Perspectives :: Research


COVID Vaccine Developer/Manufacturer Announcements [relevant press releases/announcement from organizations from WHO EUL/PQ listing above]


Press Releases – No new digest announcements identified

BioCubaFarma – Cuba
Últimas Noticias
Aprueba el CECMED autorizo de uso de Emergencias de Abdala
09/07/2021 15:43:46    |   BioCubaFarma

[google translate: CECMED approves authorization for the use of Abdala Emergencies]

Esquema de dos dosis de Soberana 02 con una dosis de Soberana Plus alcanza 91,2 por ciento de eficacia.
09/07/2021 01:21:46    |   BioCubaFarma

[google translate: Scheme of two doses of Soberana 02 with one dose of Soberana Plus achieves 91.2 percent efficacy.]

Umelisa SARS-COV-2 antígeno, un sistema de diagnóstico 100 % cubano
05/07/2021 12:02:41    |   Redacción de Granma

[google translate: Umelisa SARS-COV-2 antigen, a 100% Cuban diagnostic system]


News – No new digest announcements identified

Clover Biopharmaceuticals – China
Jun 30,2021 Clover Announces Advance Purchase Agreement with Gavi for Over 400 Million Doses of Clover’s COVID-19 Vaccine for the COVAX Facility

Jun 30,2021 Clover and Dynavax Announce Commercial Supply Agreement of Dynavax’s CpG 1018 Adjuvant for Clover’s COVID-19 Vaccine Candidate


Curevac [Bayer Ag – Germany]
Jul 6,2021
Clover Biopharmaceuticals Completes Enrollment of Adult and Elderly Population in SPECTRA Global Phase 2/3 Clinical Trial for its COVID-19 Vaccine Candidate


Gamaleya National Center
Latest News and Events – No new digest announcements identified [See Russia/RFID below]

Home – No new digest announcements


Press Releases
Jul 09, 2021 United States
Johnson & Johnson Statement on U.S. Government Donations of Company’s COVID-19 Vaccine
NEW BRUNSWICK, N.J., July 9, 2021 – Johnson & Johnson welcomes the U.S. government’s decision to donate an initial 12 million doses of the Company’s COVID-19 vaccine through the COVAX Facility.
The United States is sharing the doses via COVAX to multiple lower-income countries across three continents. The first shipment of 1.5 million doses arrived in Afghanistan on July 9, 2021.
In the coming weeks, it is anticipated that the U.S. will allocate a second tranche of Johnson & Johnson COVID-19 vaccines to additional lower-income countries. Separately, the U.S. has already donated 8 million doses of the Company’s vaccine via a series of bilateral agreements with higher-income countries including Brazil, Colombia, Mexico and South Korea.
“Equitable global access is at the forefront of Johnson & Johnson’s COVID-19 response. We strongly support the leadership shown by the Biden-Harris Administration in ensuring lifesaving COVID-19 vaccines can be redirected to where public health needs are most pressing,” said Paul Stoffels, M.D., Chief Scientific Officer and Vice Chairman of the Executive Committee, Johnson & Johnson. “We believe that a single-shot, easy to distribute COVID-19 vaccine is an essential tool to combat the pandemic globally.”…


Press Releases
July 7, 2021
Moderna Announces First Participant Dosed in Phase 1/2 Study of Its Quadrivalent Seasonal Flu mRNA Vaccine
:: mRNA-1010 is Moderna’s first seasonal influenza vaccine candidate to enter the clinic
:: mRNA-1010 is a quadrivalent seasonal influenza vaccine candidate targeting WHO recommendations including A H1N1, H3N2 and influenza B Yamagata and Victoria lineages
:: Moderna’s vision is to develop a respiratory vaccine for the adult and elderly populations combining seasonal flu, COVID-19 variant booster and RSV


Press Releases – No new digest announcements identified


Recent Press Releases – No new digest announcements identified


Sanofi Pasteur
Press Releases – No new digest announcements identified


Serum Institute of India
NEWS & ANNOUNCEMENTS – No corporate announcements identified
[Last media release still posted is dated February 15, 2021; media release of April 21, 2021 apparently removed]


News – No new digest announcements identified


Press Releases – No new digest announcements identified


Vector State Research Centre of Viralogy and Biotechnology
Home – No new digest announcements identified

Zhifei Longcom, China
[Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.]
[No website identified]



Press releases for media – No new digest announcements identified


SK Biosciences
Press releases – No new digest announcements identified